| 000 | 01863 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250511201728.0 | ||
| 264 | 0 | _c19910904 | |
| 008 | 199109s 0 0 eng d | ||
| 022 | _a0027-8424 | ||
| 024 | 7 |
_a10.1073/pnas.88.15.6550 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchaefer, B C | |
| 245 | 0 | 0 |
_aExclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. _h[electronic resource] |
| 260 |
_bProceedings of the National Academy of Sciences of the United States of America _cAug 1991 |
||
| 300 |
_a6550-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigens, Viral _xgenetics |
| 650 | 0 | 4 |
_aAzacitidine _xpharmacology |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 |
_aBurkitt Lymphoma _xgenetics |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aCloning, Molecular |
| 650 | 0 | 4 | _aEpstein-Barr Virus Nuclear Antigens |
| 650 | 0 | 4 | _aExons |
| 650 | 0 | 4 |
_aHerpesvirus 4, Human _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphocytes _ximmunology |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aOligonucleotide Probes |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xdrug effects |
| 650 | 0 | 4 |
_aRNA, Neoplasm _xgenetics |
| 650 | 0 | 4 |
_aRNA, Viral _xgenetics |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRestriction Mapping |
| 650 | 0 | 4 | _aTranscription, Genetic |
| 700 | 1 | _aWoisetschlaeger, M | |
| 700 | 1 | _aStrominger, J L | |
| 700 | 1 | _aSpeck, S H | |
| 773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 88 _gno. 15 _gp. 6550-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.88.15.6550 _zAvailable from publisher's website |
| 999 |
_c1720083 _d1720083 |
||